- Home
- RNTX vs TOP Comparison
RNTX vs TOP Comparison
Compare RNTX & TOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNTX
- TOP
- Stock Information
- Founded
- RNTX 2001
- TOP 2015
- Country
- RNTX United States
- TOP Hong Kong
- Employees
- RNTX N/A
- TOP N/A
- Industry
- RNTX Biotechnology: Pharmaceutical Preparations
- TOP Investment Bankers/Brokers/Service
- Sector
- RNTX Health Care
- TOP Finance
- Exchange
- RNTX Nasdaq
- TOP Nasdaq
- Market Cap
- RNTX 40.3M
- TOP 44.1M
- IPO Year
- RNTX N/A
- TOP 2022
- Fundamental
- Price
- RNTX $1.56
- TOP $1.21
- Analyst Decision
- RNTX
- TOP
- Analyst Count
- RNTX 0
- TOP 0
- Target Price
- RNTX N/A
- TOP N/A
- AVG Volume (30 Days)
- RNTX 33.6K
- TOP 59.7K
- Earning Date
- RNTX 08-13-2025
- TOP 07-29-2025
- Dividend Yield
- RNTX N/A
- TOP N/A
- EPS Growth
- RNTX N/A
- TOP N/A
- EPS
- RNTX N/A
- TOP N/A
- Revenue
- RNTX N/A
- TOP $2,730,890.00
- Revenue This Year
- RNTX N/A
- TOP N/A
- Revenue Next Year
- RNTX N/A
- TOP N/A
- P/E Ratio
- RNTX N/A
- TOP N/A
- Revenue Growth
- RNTX N/A
- TOP N/A
- 52 Week Low
- RNTX $1.35
- TOP $1.00
- 52 Week High
- RNTX $4.40
- TOP $1.94
- Technical
- Relative Strength Index (RSI)
- RNTX N/A
- TOP 47.17
- Support Level
- RNTX N/A
- TOP $1.23
- Resistance Level
- RNTX N/A
- TOP $1.29
- Average True Range (ATR)
- RNTX 0.00
- TOP 0.07
- MACD
- RNTX 0.00
- TOP -0.01
- Stochastic Oscillator
- RNTX 0.00
- TOP 13.81
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.